Purple Biotech (PPBT) Research & Development (2014 - 2026)
Purple Biotech's (PPBT) quarterly Research & Development came in at $1.2 million in Q1 2026, up 61.84% year-on-year from $760000.0 in Q1 2025, and down 32.75% on a QoQ basis from $1.8 million in Q4 2025.
Purple Biotech (PPBT) Research & Development (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 12 years of Research & Development data on file, last reported at $1.2 million in Q1 2026.
- On a quarterly basis, Research & Development rose 61.84% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $4.2 million, a 15.29% decrease from a year earlier, with the FY2025 full-year figure at $3.7 million, down 51.04% from the prior year.
- Research & Development for Q1 2026 stood at $1.2 million, down from $1.8 million in the prior quarter.
- Over the last five years, Research & Development for PPBT reached as high as $6.0 million in Q1 2022 and fell as low as $458000.0 in Q4 2024.
- Historically, Research & Development has averaged $2.7 million across 5 years, with a median of $2.4 million in 2024.
- Across the five-year window, Research & Development tumbled 91.26% in 2024 and surged 299.34% in 2025, its largest moves.
- Year by year, Research & Development stood at $4.8 million in 2022, then rose by 8.76% to $5.2 million in 2023, then tumbled by 91.26% to $458000.0 in 2024, then jumped by 299.34% to $1.8 million in 2025, then tumbled by 32.75% to $1.2 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $1.2 million in Q1 2026, $1.8 million in Q4 2025, and $587000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Purple Biotech | 1.33 Bn | 1.33 Bn | - | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 587,000.00 |
| Jun 30, 2025 | 553,000.00 |
| Mar 31, 2025 | 760,000.00 |
| Dec 31, 2024 | 458,000.00 |
| Sep 30, 2024 | 1.35 Mn |
| Jun 30, 2024 | 2.39 Mn |
| Mar 31, 2024 | 3.42 Mn |
| Dec 31, 2023 | 5.24 Mn |
| Sep 30, 2023 | 4.59 Mn |
| Jun 30, 2023 | 3.71 Mn |
| Mar 31, 2023 | 3.50 Mn |
| Dec 31, 2022 | 4.82 Mn |
| Sep 30, 2022 | 3.47 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Mar 31, 2022 | 5.95 Mn |
| Dec 31, 2021 | 4.87 Mn |
| Sep 30, 2021 | 1.62 Mn |
| Jun 30, 2021 | 2.09 Mn |